Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rabies Inactivated Vaccine CTN-1 Strain
- Development stage
- Unknown
- Lead developer
- Sinovac Biotech
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
Rabies Inactivated Vaccine CTN-1 Strain is an inactivated veterinary vaccine developed by Tangshan Yian Biological Engineering, a subsidiary of Sinovac Biotech. It utilizes the CTN-1 strain of the rabies virus, which is a fixed strain adapted for cell culture production. The vaccine is designed to prevent rabies in animals by inducing the production of protective neutralizing antibodies against the rabies virus glycoprotein. It received production license approval from China's Ministry of Agriculture in September 2011 and is marketed under the brand name RabEnd. This product represents Tangshan Yian's entry into the veterinary vaccine market and is specifically formulated for animal health applications.
- Brand names
- RabEnd
- Other names
- 狂犬病灭活疫苗CTN-1株Rabies Inactivated Vaccine CTN-1 Strain Animal
02
Targets
RABV-G (Rabies virus glycoprotein)
Beyond the preview
Go deeper on Rabies Inactivated Vaccine CTN-1 Strain.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rabies Inactivated Vaccine CTN-1 Strain.